Cargando…
S118: A CHEMOTHERAPY-FREE COMBINATION OF PONATINIB AND BLINATUMOMAB FOR PATIENTS WITH NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA: SUBGROUP ANALYSIS FROM A PHASE II STUDY
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428386/ http://dx.doi.org/10.1097/01.HS9.0000967384.49681.52 |
| _version_ | 1785090456644747264 |
|---|---|
| author | Short, Nicholas Jabbour, Elias Jain, Nitin Huang, Xuelin Macaron, Walid Nasr, Lewis Montalban-Bravo, Guillermo Kadia, Tapan Daver, Naval Chien, Kelly Alvarado, Yesid Issa, Ghayas Haddad, Fadi Nasnas, Cedric Zoghbi, Marianne Garris, Rebecca Konopleva, Marina Ravandi, Farhad Kantarjian, Hagop |
| author_facet | Short, Nicholas Jabbour, Elias Jain, Nitin Huang, Xuelin Macaron, Walid Nasr, Lewis Montalban-Bravo, Guillermo Kadia, Tapan Daver, Naval Chien, Kelly Alvarado, Yesid Issa, Ghayas Haddad, Fadi Nasnas, Cedric Zoghbi, Marianne Garris, Rebecca Konopleva, Marina Ravandi, Farhad Kantarjian, Hagop |
| author_sort | Short, Nicholas |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428386 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104283862023-08-17 S118: A CHEMOTHERAPY-FREE COMBINATION OF PONATINIB AND BLINATUMOMAB FOR PATIENTS WITH NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA: SUBGROUP ANALYSIS FROM A PHASE II STUDY Short, Nicholas Jabbour, Elias Jain, Nitin Huang, Xuelin Macaron, Walid Nasr, Lewis Montalban-Bravo, Guillermo Kadia, Tapan Daver, Naval Chien, Kelly Alvarado, Yesid Issa, Ghayas Haddad, Fadi Nasnas, Cedric Zoghbi, Marianne Garris, Rebecca Konopleva, Marina Ravandi, Farhad Kantarjian, Hagop Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428386/ http://dx.doi.org/10.1097/01.HS9.0000967384.49681.52 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Oral Sessions Short, Nicholas Jabbour, Elias Jain, Nitin Huang, Xuelin Macaron, Walid Nasr, Lewis Montalban-Bravo, Guillermo Kadia, Tapan Daver, Naval Chien, Kelly Alvarado, Yesid Issa, Ghayas Haddad, Fadi Nasnas, Cedric Zoghbi, Marianne Garris, Rebecca Konopleva, Marina Ravandi, Farhad Kantarjian, Hagop S118: A CHEMOTHERAPY-FREE COMBINATION OF PONATINIB AND BLINATUMOMAB FOR PATIENTS WITH NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA: SUBGROUP ANALYSIS FROM A PHASE II STUDY |
| title | S118: A CHEMOTHERAPY-FREE COMBINATION OF PONATINIB AND BLINATUMOMAB FOR PATIENTS WITH NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA: SUBGROUP ANALYSIS FROM A PHASE II STUDY |
| title_full | S118: A CHEMOTHERAPY-FREE COMBINATION OF PONATINIB AND BLINATUMOMAB FOR PATIENTS WITH NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA: SUBGROUP ANALYSIS FROM A PHASE II STUDY |
| title_fullStr | S118: A CHEMOTHERAPY-FREE COMBINATION OF PONATINIB AND BLINATUMOMAB FOR PATIENTS WITH NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA: SUBGROUP ANALYSIS FROM A PHASE II STUDY |
| title_full_unstemmed | S118: A CHEMOTHERAPY-FREE COMBINATION OF PONATINIB AND BLINATUMOMAB FOR PATIENTS WITH NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA: SUBGROUP ANALYSIS FROM A PHASE II STUDY |
| title_short | S118: A CHEMOTHERAPY-FREE COMBINATION OF PONATINIB AND BLINATUMOMAB FOR PATIENTS WITH NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA: SUBGROUP ANALYSIS FROM A PHASE II STUDY |
| title_sort | s118: a chemotherapy-free combination of ponatinib and blinatumomab for patients with newly diagnosed philadelphia chromosome-positive acute lymphoblastic leukemia: subgroup analysis from a phase ii study |
| topic | Oral Sessions |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428386/ http://dx.doi.org/10.1097/01.HS9.0000967384.49681.52 |
| work_keys_str_mv | AT shortnicholas s118achemotherapyfreecombinationofponatinibandblinatumomabforpatientswithnewlydiagnosedphiladelphiachromosomepositiveacutelymphoblasticleukemiasubgroupanalysisfromaphaseiistudy AT jabbourelias s118achemotherapyfreecombinationofponatinibandblinatumomabforpatientswithnewlydiagnosedphiladelphiachromosomepositiveacutelymphoblasticleukemiasubgroupanalysisfromaphaseiistudy AT jainnitin s118achemotherapyfreecombinationofponatinibandblinatumomabforpatientswithnewlydiagnosedphiladelphiachromosomepositiveacutelymphoblasticleukemiasubgroupanalysisfromaphaseiistudy AT huangxuelin s118achemotherapyfreecombinationofponatinibandblinatumomabforpatientswithnewlydiagnosedphiladelphiachromosomepositiveacutelymphoblasticleukemiasubgroupanalysisfromaphaseiistudy AT macaronwalid s118achemotherapyfreecombinationofponatinibandblinatumomabforpatientswithnewlydiagnosedphiladelphiachromosomepositiveacutelymphoblasticleukemiasubgroupanalysisfromaphaseiistudy AT nasrlewis s118achemotherapyfreecombinationofponatinibandblinatumomabforpatientswithnewlydiagnosedphiladelphiachromosomepositiveacutelymphoblasticleukemiasubgroupanalysisfromaphaseiistudy AT montalbanbravoguillermo s118achemotherapyfreecombinationofponatinibandblinatumomabforpatientswithnewlydiagnosedphiladelphiachromosomepositiveacutelymphoblasticleukemiasubgroupanalysisfromaphaseiistudy AT kadiatapan s118achemotherapyfreecombinationofponatinibandblinatumomabforpatientswithnewlydiagnosedphiladelphiachromosomepositiveacutelymphoblasticleukemiasubgroupanalysisfromaphaseiistudy AT davernaval s118achemotherapyfreecombinationofponatinibandblinatumomabforpatientswithnewlydiagnosedphiladelphiachromosomepositiveacutelymphoblasticleukemiasubgroupanalysisfromaphaseiistudy AT chienkelly s118achemotherapyfreecombinationofponatinibandblinatumomabforpatientswithnewlydiagnosedphiladelphiachromosomepositiveacutelymphoblasticleukemiasubgroupanalysisfromaphaseiistudy AT alvaradoyesid s118achemotherapyfreecombinationofponatinibandblinatumomabforpatientswithnewlydiagnosedphiladelphiachromosomepositiveacutelymphoblasticleukemiasubgroupanalysisfromaphaseiistudy AT issaghayas s118achemotherapyfreecombinationofponatinibandblinatumomabforpatientswithnewlydiagnosedphiladelphiachromosomepositiveacutelymphoblasticleukemiasubgroupanalysisfromaphaseiistudy AT haddadfadi s118achemotherapyfreecombinationofponatinibandblinatumomabforpatientswithnewlydiagnosedphiladelphiachromosomepositiveacutelymphoblasticleukemiasubgroupanalysisfromaphaseiistudy AT nasnascedric s118achemotherapyfreecombinationofponatinibandblinatumomabforpatientswithnewlydiagnosedphiladelphiachromosomepositiveacutelymphoblasticleukemiasubgroupanalysisfromaphaseiistudy AT zoghbimarianne s118achemotherapyfreecombinationofponatinibandblinatumomabforpatientswithnewlydiagnosedphiladelphiachromosomepositiveacutelymphoblasticleukemiasubgroupanalysisfromaphaseiistudy AT garrisrebecca s118achemotherapyfreecombinationofponatinibandblinatumomabforpatientswithnewlydiagnosedphiladelphiachromosomepositiveacutelymphoblasticleukemiasubgroupanalysisfromaphaseiistudy AT konoplevamarina s118achemotherapyfreecombinationofponatinibandblinatumomabforpatientswithnewlydiagnosedphiladelphiachromosomepositiveacutelymphoblasticleukemiasubgroupanalysisfromaphaseiistudy AT ravandifarhad s118achemotherapyfreecombinationofponatinibandblinatumomabforpatientswithnewlydiagnosedphiladelphiachromosomepositiveacutelymphoblasticleukemiasubgroupanalysisfromaphaseiistudy AT kantarjianhagop s118achemotherapyfreecombinationofponatinibandblinatumomabforpatientswithnewlydiagnosedphiladelphiachromosomepositiveacutelymphoblasticleukemiasubgroupanalysisfromaphaseiistudy |